|
 |
RosuvastatinThis page contains recent news articles, when available, and an overview of Rosuvastatin but does not offer medical advice. You should contact your physician with regard to any health issues or concerns.Overview: Rosuvastatin (when available) Rosuvastatin is an antilipemic agent and a competitive HMG-CoA reductase inhibitor effective in lowering LDL cholesterol and triglycerides. It is used to treat primary hypercholesterolemia and mixed dyslipidemia (Fredrickson types IIa and IIb). For the treatment of pure hypercholesterolaemia and mxed hyperlipidaemia Mechanism Of Action: Rosuvastatin selectively and competitively inhibits the hepatic enzyme hydroxymethylglutaryl-coenzyme A (HMG-CoA) reductase. As HMG-CoA reductase is responsible for converting HMG-CoA to mevalonate, this results in a decrease in mevalonate, a precursor of cholesterol, and a subsequent decrease in hepatic cholesterol levels and increase in uptake of LDL cholesterol. News Articles on Rosuvastatin FDA Panel Backs Statin for Primary Prevention - Dec 15, 2009 If the FDA follows the panel's recommendation, rosuvastatin would be the first statin approved for primary prevention of heart disease. ... MedPage Today Statins May Provide Benefit Despite Low LDL Patients with low cholesterol and ... - Dec 15, 2009 Applying the reduction in events from rosuvastatin treatment in the JUPITER trial, they estimated that 38 individuals would have to be treated to prevent ... ModernMedicine Statins Found to Be Beneficial in Congestive Heart Failure Drug class improves ... - Dec 28, 2009 ...and colleagues conducted a meta-analysis of 10 studies involving 10192 patients, including three studies randomizing patients to rosuvastatin, ... ModernMedicine Several widely prescribed drugs to come under pharmacovigilance programme soon - Jan 3, 2010 ...nasal decongestant phenylpropanolamine, antibiotic drug gatifloxacine, fertility drug letrozole, lipid lowering cholesterol control agent rosuvastatin, ... pharmabiz.com INSIDERMEDICINE VIDEO: Less Education Linked to More Asthma Problems, FDA ... - Dec 16, 2009 From Washington – The FDA is now recommending that rosuvastatin can be used for preventive purposes, even in patients with no history of atherosclerosis. ... Insidermedicine Advisory Committee Briefing Materials for CRESTOR(R) sNDA Available on US FDA ... - Dec 11, 2009 Results from the primary analysis of JUPITER (Justification for the Use of statins in Prevention: an Intervention Trial Evaluating Rosuvastatin) were ... CNNMoney.com (press release) FDA panel votes to recommend approval of new indication for rosuvastatin - Dec 15, 2009 The Endocrinologic and Metabolic Drugs Advisory Committee voted 12 to 4 (with one abstaining) to recommend approval of rosuvastatin calcium tablets (Crestor ... Cardiology Today Painkillers, antibiotics among nine drugs under govt watch - Dec 30, 2009 These drugs include 'Rosuvastatin' used as lipid lowering cholesterol-control agent, COX-2 Inhibitors used as pain killer, Phenylpropylamine for nasal ... Times of India AstraZeneca to acquire Novexel and work with Forest Laboratories - Dec 30, 2009 Earlier this month, AstraZeneca's chief medical officer welcomed approval from the Food and Drug Administration (FDA) regarding its CRESTOR (rosuvastatin ... Zenopa AHA: Focus on cardiovascular health, not disease - Dec 18, 2009 Lloyd-Jones said he can see some irony in the recent US expanded approval for rosuvastatin (Crestor) to include patients with normal LDL-cholesterol levels ... TheHeart.Org Most Carotid Stenosis Cases Treatable with Medical Therapy - Dec 14, 2009 The intensive treatment included giving maximum tolerated doses of statin drugs, such as 80 mg of atorvastatin (Lipitor) or 40 mg of rosuvastatin (Crestor), ... MedPage Today Analysis Finds CRP Fits Well with Conventional Risk Factors - Dec 21, 2009 Dehmer said that a number of recent pronouncements involving CRP -- including an FDA advisory panel's recommendation last week to expand the rosuvastatin ... MedPage Today Crestor Even Better For You Than Previously Thought - Dec 21, 2009 Crestor, (rosuvastatin) is an extremely effective statin which prevents the production of harmful cholesterol in the human liver. ... UKMedix Health News Abbott Labs' Deal with Teva Pharma Is 'Phat News' for Lipid-Lowering Franchise - Dec 14, 2009 The sales force of British-based AstraZaneca, drug manufacturer of the $3.6 billion statin Crestor (rosuvastatin), began co-promoting TriLipix during the ... BNET Morning news wrap: AstraZeneca, Petrofac, Punch Taverns, Drax Group, Allocate ... - Dec 16, 2009 ...established sufficient benefit to offset the observed risk to support the use of CRESTOR (rosuvastatin calcium) in individuals meeting certain criteria. ... Proactive Investors UK FDA considers statin use for those with normal cholesterol - Dec 22, 2009 It would also mean that roughly 6 million new patients would be eligible to take a statin -- in this case, Crestor (rosuvastatin). ... CNN International C-Reactive Protein No Cause of Heart Trouble: Study - Dec 22, 2009 A major study last year called Jupiter showed that giving AstraZeneca's cholesterol fighter Crestor, or rosuvastatin, cut deaths, heart attacks and strokes ... ABC News Zacks Analyst Blog Highlights: AstraZeneca, Pfizer, Mylan Laboratories ... - Dec 29, 2009 ...the JUPITER (Justification for the Use of statins in Prevention: an Intervention Trial Evaluating Rosuvastatin) study conducted with 18000 patients. ... FOXBusiness FDA-Gutachter für breiteren Einsatz von Rosuvastatin - Dec 16, 2009 Washington – US-Ärzte dürfen den Lipidsenker Rosuvastatin vermutlich bald auch offiziell bei Patienten einsetzen, die gar keine erhöhten Cholesterinwerte ... Deutsches Ärzteblatt 美 'í?¬ë ˆìŠ¤í† ' 예방ì ? 사용 승ì?¸ê¶Œê³ - Dec 15, 2009 ...미êµì—?ì„œ ì½œë ˆìŠ¤í…Œë¡¤ ì €í•˜ì œ 'í?¬ë ˆìŠ¤í† '(Crestor, rosuvastatin)ê°€ 심혈관 질환ì?˜ 예방ì ? 사용ì—? 승ì?¸ì?´ ê¶Œê³ ë??다. ë¯¸êµ FDA ìž?문위ì›?회는 12대 4ë¡œ 현재 치료 ê°€ì?´ë“œ ... 디지틀보사 Expertpanel ser positivt pÃ¥ utvidgad Crestor-indikation - Dec 16, 2009 I november 2008 publicerades huvudresultaten i den sÃ¥ kallade Jupiter-studien, där läkemedlet Crestor (rosuvastatin) undersökts hos tidigare hjärtfriska ... Dagens Medicin 2010ë…„ 8ê°œ 블ë¡?버스터 ì‹ ì•½ 출시 - Dec 29, 2009 ...아스트ë?¼ì œë„¤ì¹´ì™€ ì• ë³´íŠ¸ê°€ ê³µë?™ 개발한 서트리어드(rosuvastatin+fenofibric acid)는 'í?¬ë ˆìŠ¤í† '(Crestor)와 '트리리픽스'(TriLipix)를 ê³ ì •ìš©ëŸ‰ìœ¼ë¡œ 복합해 편리하게 ... 디지틀보사 La FDA donne un avis favorable à la prescription de rosuvastatine guidée par ... - Dec 22, 2009 Trial Evaluating Rosuvastatin), présentée pour la première fois à l'AHA 2008 et publiée conjointement dans le New England Journal of Medicine. ... theheart.org/fr Τα πιο ελπιδοφόÏ?α νÎα του 2009 - Dec 19, 2009 ελάμβαναν rosuvastatin (Crestor) είχαν λιγότεÏ?ες πιθανότητες να υποστοÏ?ν καÏ?διακή Ï€Ï?οσβολή ή εγκεφαλικό σε σÏ?γκÏ?ιση με τους συμμετÎχοντες στη μελÎτη, ... Η Καθημερινή 'í?¬ë ˆìŠ¤í† ' ì ?ì?‘ì¦? 추가 í—ˆê°€ê¶Œê³ ì˜ˆì?˜ - Dec 14, 2009 ...쥬피터 시험ì?€ 'Justification for the Use of statins in Primary prevention: an Intervention Trial Evaluating Rosuvastatin'ì?˜ 약ìž?ì?´ë‹¤. ... 약업신문 Ð?Ñ?траЗенека» Ñ? воодушевлением принÑ?ла положительный результат голоÑ?ованиÑ? FDA - Dec 22, 2009 Обзор, оÑ?нованный на результатах иÑ?Ñ?ледованиÑ? JUPITER (Justification for the Use of statins in Prevention: an Intervention Trial Evaluating Rosuvastatin ... Российские аптеки (пресс-релиз) 10 أخبار صØية كبرى لعام 2009 - Dec 12, 2009 Ø®Ù?ض خطر تعرضهم لنوبة قلبية إلى النصÙ? بتناولهم لجرعة عالية (20 ملغم) من دواء قوي من أدوية الستاتين وهو «روزÙ?استاتين» rosuvastatin («كريستور» Crestor). ... الشرق الاوسط Simcere Pharmaceutical Group to Acquire China Manufacturing License for ... - Nov 9, 2009 Rosuvastatin was first marketed by Astrazeneca as Crestor in 2003 and is an effective statin to treat high cholesterol and related conditions. ... CNNMoney.com (press release) Statins may reduce severe H1N1 death risk - Nov 13, 2009 One group will receive the statin rosuvastatin, Crestor, every day for the duration of their hospital stay, and the other group will receive a placebo. ... United Press International CORONA analysis reopens door for statins in heart failure - Nov 3, 2009 ..."Patients with lower plasma concentrations of NT-proBNP had a lower event rate but seemed to obtain greater benefit from rosuvastatin," according to ... TheHeart.Org What Risks Are Associated With High-Dose Rosuvastatin? - Oct 22, 2009 Rosuvastatin, a hydroxy-methylglutaryl coenzyme A reductase inhibitor, is approved in doses ranging from 5 mg to 40 mg daily. [1] Rosuvastatin is a potent ... Medscape Patients With Type 2 Diabetes Can Reach LDL Target With Single Uptitration of ... - Oct 27, 2009 In the algorithm, those with a baseline LDL cholesterol level of >2.0 but <2.5 mmol/L were initiated on rosuvastatin 10 mg. If the baseline LDL cholesterol ... DG News AstraZeneca's CRESTOR approved for treating pediatric patients with HeFH - Oct 19, 2009 In July, AstraZeneca announced the FDA had granted an additional six-month period of exclusivity to market CRESTOR® (rosuvastatin calcium) for its approved ... News-Medical.net Protecting patients during influenza season especially important this year - Nov 2, 2009 Bernard and colleagues are examining the utility of rosuvastatin (Crestor, AstraZeneca) vs. placebo in hospital mortality to 28 days, or time to resolution ... Cardiology Today SCR: To Acquire Manufacturing License in China for Rosuvastatin (Crestor) - Nov 9, 2009 Simcere Pharmaceutical Group (SCR) announced an agreement to acquire the manufacturing license in China of Rosuvastatin from Tianjin Tianda Pharmaceutical ... Trading Markets (press release) Cholesterol Drug Crestor Approved for Children - Oct 27, 2009 The US Food and Drug Administration (FDA) has approved the use of Crestor, generic name rosuvastatin, for lowering cholesterol for children and teens with a ... eMaxHealth Buy On-line - crestor side effects - Oct 31, 2009 Daily use of CRESTOR side effects of rosuvastatin between the elderly patients. You may need legal help. Low those listed above contact your healthcare ... Newstalk ZB Statin drugs may lower deaths from flu: study - Oct 29, 2009 Statin drugs include AstraZeneca's Crestor, known generically as rosuvastatin, Bristol-Myers Squibb Pravachol or pravastatin and Merck's Mevacor, ... Reuters Crestor Reduces Lipids Better Than Pravachol in People With HIV - Oct 27, 2009 Crestor (rosuvastatin) is better than Pravachol (pravastatin) in reducing triglycerides and low-density lipoprotein (LDL) levels—“badâ€? cholesterol levels—in ... AIDSmeds.com HIV/AIDS Treatment News BREAKING NEWS: AstraZeneca sales boosted by swine flu vaccine - Oct 29, 2009 Turnover from Crestor (rosuvastatin) increased 30% to $1.15 billion and in the USA, total prescriptions increased 25%, compared with 6% for the statin ... Pharma Times Red Yeast Rice and Hyperlipidemia: How Strong Is the Evidence? - Oct 28, 2009 For example, in a 2009 study, within 12 months of the initiation of treatment, rosuvastatin was associated with significant regression of carotid ... Medscape AstraZeneca withdraws filings for lung cancer drug - Nov 2, 2009 Seroquel (quetiapine) for schizophrenia and cholesterol-lowerer Crestor (rosuvastatin). Just ahead of the marketing submissions, analysts at Jefferies ... Pharmafocus AZ-BMS launch Onglyza in Europe - Oct 19, 2009 Also in the US, the FDA has approved AstraZeneca's Crestor (rosuvastatin calcium) for use in children ages 10-17 with genetic disease heterozygous familial ... Pharmafocus Simcere Pharma收è´ä¸å›½çš„Rosuvastatinåˆ¶é€ è®¸å?¯ - Nov 10, 2009 Simcere Pharmaç¾ç½²å??议，将å?‘Tianjin Tianda Pharmaceutical Co收è´ä¸å›½çš„Rosuvastatinåˆ¶é€ è®¸å?¯ã€‚ æ ¹æ?®å??议，Simcere Pharmaå°†é€?过入股Tianda，以å?ŠTianda转移特定 ... 凤凰网 Simcere Pharma收è´Rosuvastatin在ä¸å›½çš„åˆ¶é€ è®¸å?¯ - Nov 9, 2009 ...(SCR) 7.69 :Simcere Pharma宣布ç¾ç½²å??议，跟Tianjin Tianda Pharmaceutical Co收è´ä¸å›½çš„Rosuvastatinåˆ¶é€ è®¸å?¯ï¼Œå°†é€?过入股Tianda，以å?ŠTianda转移特定技术 ... 凤凰网 FDA одобри rosuvastatin при педиатрична фамилна хиперхолеÑ?теролемиÑ? 20 ... - Oct 20, 2009 Ð?мериканÑ?ката админиÑ?трациÑ? по храните и лекарÑ?твата (FDA) одобри rosuvastatin (Crestor, AstraZeneca) за употреба при деца на възраÑ?Ñ‚ между 10 и 17 години Ñ? ... DoctorBG.com í?¬ë ˆìŠ¤í† , 죽ìƒ?ë?™ë§¥ê²½í™”ì¦? 퇴행 재입ì¦? - Nov 1, 2009 ...코스모스(COSMOS, COronary atherosclerosis Study Measuring effects Of rosuvastatin using intravascular ultrasound in Japanese Subjects; ì?¼ë³¸ì?¸ 환ìž?êµ°ì—? 대한 ... 디지틀보사 FDA, AZ 'í?¬ë ˆìŠ¤í† ' ì²ì†Œë…„ì—? ì‚¬ìš©í† ë¡? 허가 - Oct 20, 2009 ...김윤ì˜? 기ìž? ë¯¸êµ FDA는 í?¬ë ˆìŠ¤í† (Crestor: rosuvastatin)를 10-17세 ì²ì†Œë…„ 가족 ìœ ì „ì„± ê³ ì§€í˜ˆì¦? 환ìž? 치료ì—? 사용ì?„ PLUTO ìž„ìƒ?연구 ìž?료ì—? 근거해 허가했다. ... 메디포뉴스 'í?¬ë ˆìŠ¤í† ' ì ?ì?‘ì¦? 플러스‧ '심 - Oct 18, 2009 FDA는 PLUTO 시험(Pediatric Lipid-redUction Trial of rOsuvastatin) 결과를 근거로 ì?´ë²ˆì—? ì ?ì?‘ì¦? 추가를 승ì?¸í•œ 것으로 í’€ì?´ë?˜ê³ 있다. ... 약업신문 AUDIO: LAS MEDICINAS GENÉRICAS SON ECONÓMICAS PERO ES IMPORTANTE SABER QUE SU ... - Oct 29, 2009 NO HAY UNA VERSIÓN GENÉRICA DE LA MEDICINA CONTRA EL COLESTEROL CRESTOR(R) (ROSUVASTATIN CALCIUM). CRESTOR, JUNTO CON LA DIETA, SE INDICA PARA RETRASAR LA ... Hispanic PR Wire (Comunicado de prensa) í??ê²½ 여성ì?˜ CVD risk factor 어떻게 ê´€ë¦¬í• ê²ƒì?¸ê°€? - Nov 9, 2009 ...최근ì—? JUPITER 연구ì—?ì„œ rosuvastatin 20㎎ì?´ 심혈관질환ì?˜ 위험ì?„ ê°?소하는 효과를 보였다. ë² ì?´ìŠ¤ë?¼ì?¸ì—? 비해 환ìž?ì?˜ LDL 수치가 최소 50% ê°?ì†Œí•˜ê³ hsCRPê°€ ë² ì?´ìŠ¤ ... 코리아헬스로그 FDA aprova uso de Crestor® em doentes pediátricos - Oct 19, 2009 ...de aplicação suplementar do fármaco apresentado pela AstraZeneca, que incluiu dados do estudo PLUTO ((Pediatric Lipid-redUction Trial of rOsuvastatin). ... RCM Pharma Healthy people may benefit from statins too - Nov 10, 2008 The new study focused on a specific drug -- rosuvastatin, ... Half of the patients received 20 milligrams of rosuvastatin and half a placebo. ... Los Angeles Times Does rosuvastatin improve lipid levels in patients with the metabolic... - Oct 9, 2005 Stalenhoef AFH et al. (2005) A COmparative study with rosuvastatin in subjects with METabolic Syndrome: results of the COMETS study. ... Nature.com Advice about rosuvastatin (Crestor) - Nov 6, 2008 The Committee on Safety of Medicines has published this advice to doctors about prescribing rosuvastatin (Crestor).[1] ... guardian.co.uk Drugs 'can reverse heart disease' - Mar 14, 2006 They were given intensive treatment with rosuvastatin, ... Rosuvastatin has previously been linked to a small number of cases of a muscle wasting disease. ... BBC News Statin therapy slows progression of arterial thickening - Mar 27, 2007 ..."Rosuvastatin treatment was associated with a 49 percent reduction in LDL-C ... "Compared with placebo, rosuvastatin significantly slowed progression of the ... Hindu Rosuvastatin pharmacokinetics and pharmacogenetics in white and … - May 5, 2005 1 National University Hospital and Changi General Hospital, Singapore; AstraZeneca, Wilmington; and AstraZeneca, Alderley Park, Macclesfield. ... Nature.com Astrazeneca's Crestor gets FDA approval for atherosclerosis - Nov 9, 2007 ...has approved Crestor, or rosuvastatin calcium, as an adjunct to diet, to slow the progression of atherosclerosis in patients with elevated cholesterol. ... MarketWatch Shrinking plaque - Mar 26, 2006 ASTEROID (A Study To Evaluate the Effect of Rosuvastatin On Intravascular ... In the study, rosuvastatin was well tolerated by the patients and adverse ... Malaysia Star FDA issues rosuvastatin advisory highlighting revised label - Mar 2, 2005 Wilmington, DE - The Food and Drug Administration (FDA) issued a public-health advisory on rosuvastatin (Crestor®) today that highlights a revised package ... Medscape Crestor slows plaque growth in low-risk patients - Mar 26, 2007 Crestor, known chemically as rosuvastatin, had previously shown impressive plaque reduction in an earlier study of patients with advanced atherosclerosis. ... Reuters No Efficacy Benefits Seen With Rosuvastatin Against Placebo in GISSI... - Sep 2, 2008 By Chris Berrie. MUNICH, Germany -- September 2, 2008 -- Rosuvastatin 10 mg daily shows a good safety profile but no benefit over placebo for patients with ... DG News Rosuvastatin vs Atorvastatin in Reducing Lipid Levels: Discussion - Nov 10, 2006 While the cholesterol-lowering effects of statins in highly controlled and randomized environments are well documented, the impact of statins on reductions ... Medscape New Study Suggests Rosuvastatin is Associated With Arresting the … - Apr 26, 2005 Results from ORION indicate that significant lowering of bad cholesterol levels (>50%) are also associated with regressing plaques at sites with the most ... Medical News Today - Medical News Today (press release) Crestor shows wider heart benefit - Nov 12, 2008 12 (UPI) -- A US study suggests the cholesterol drug rosuvastatin reduced heart attacks and strokes in patients with elevated C-reactive protein levels. ... United Press International Crestor slows plaque growth in low-risk patients - Mar 25, 2007 Crestor, known chemically as rosuvastatin, had previously shown impressive plaque reduction in an earlier study of patients with advanced atherosclerosis. ... Reuters Treatment of hypercholesterolemia in patients with the metabolic … - Oct 26, 2005 Rosuvastatin (10 mg) caused significantly greater reductions in LDL ... LDL cholesterol reduction with 10 mg rosuvastatin was 46.7% in patients with the MS ... Nature.com Article: Doctors debate best use of preventive heart drug Study shows... - Nov 15, 2008 Rosuvastatin is one of the most potent statins and has been associated ... ProHealth Care was one of the sites where the rosuvastatin trial was conducted. ... Pay-Per-View - Milwaukee Journal Sentinel - HighBeam Research AstraZeneca's Crestor fails in heart failure study - Nov 5, 2007 CORONA study was the first to test whether the 4-year-old drug, which is known generically as rosuvastatin, actually improved patient outcomes. ... Reuters … Study To Evaluate the Effect of Rosuvastatin on Intravascular... - Mar 24, 2006 For the first time, Dr. Nissen and his co-investigators believe, a clinical study has shown that very intensive cholesterol lowering with a statin drug can ... Medscape Cholesterol-fighting drug halves risk of heart attack - Nov 17, 2008 Although rosuvastatin is a relatively expensive statin, it is considerably more potent than other cheaper statins and is a cost-effective choice when more ... WalesOnline Adverse events tied to rosuvastatin - May 23, 2005 Boston, MA - Adverse events associated with rosuvastatin (Crestor, AstraZeneca) appear to be higher than with the other available statins, according to a ... Medscape Can a Potent Statin Actually Regress Coronary Atherosclerosis? - Apr 5, 2006 After 2 years of treatment with rosuvastatin, mean LDL-C levels decreased by ... Rosuvastatin therapy was associated with a modest decrease in mean percent ... Journal of American Medical Association - Journal of American Medical Association... Effect of Rosuvastatin on Progression of Carotid Intima-Media... - Mar 25, 2007 John R. Crouse III, MD; Joel S. Raichlen, MD; Ward A. Riley, PhD; Gregory W. Evans, MA; Mike K. Palmer, PhD; Daniel H. O'Leary, MD; Diederick E. Grobbee, ... Journal of American Medical Association - Journal of American Medical Association... ASTEROID: IVUS shows regression with rosuvastatin - Apr 1, 2006 ATLANTA – Aggressive treatment with rosuvastatin was associated with a regression of atherosclerotic burden assessed using intravascular ultrasound. ... Cardiology Today JUPITER: Rosuvastatin cuts CV events in people with normal LDL,... - Nov 10, 2008 By Joanna Lyford. MedWire News: The lipid-lowering drug rosuvastatin nearly halves the risk for major cardiovascular (CV) events in apparently healthy ... Medwire (subscription) … Effects of AstraZeneca's CRESTOR(R) (Rosuvastatin Calcium) on... - Nov 7, 2007 7 /PRNewswire-FirstCall/ -- A new analysis presented today from METEOR (Measuring Effects on intima media Thickness: an Evaluation Of Rosuvastatin) showed ... Free with registration - PR Newswire - AccessMyLibrary.com Rosuvastatin (Systemic). - Feb 1, 2006 Rosuvastatin roe-SOO-va-sta-tin is used to lower cholesterol and triglyceride (fat-like substances) levels in the blood. Using this medicine may help ... Free with registration - USP DI-Volume II, Advice for the... - AccessMyLibrary.com Treatment of hypercholesterolemia in patients with metabolic syndrome:... - Aug 26, 2005 To compare the effects of rosuvastatin, atorvastatin, simvastatin and ... LDL-cholesterol reduction with 10 mg rosuvastatin was 46.7% in patients with MS ... Nature.com Acute treatment with rosuvastatin protects insulin resistant (C57BL/6J... - Jan 14, 2008 This study was supported by NIH Grants HL-07731, HL-030260, and HL-065380, YF Wu Research and Education Fund, WFUSM Venture Fund, and KG Phillips Fund for ... Nature.com … /simvastatin) Is Superior To Crestorâ„¢ (rosuvastatin) In Reducing... - Oct 20, 2006 The study, which provides the first comparative data for INEGYâ„¢ versus rosuvastatin, was performed to assess the efficacy for LDL-C lowering of INEGYâ„¢ ... Medical News Today - Medical News Today (press release) Medication combo trumps rosuvastatin in cutting LDL.(Cardiovascular … - Jan 1, 2007 COPENHAGEN -- A combination of ezetimibe and simvastatin provides additional lipid-modifying benefits compared with rosuvastatin monotherapy among patients ... Free with registration - Internal Medicine News - AccessMyLibrary.com … that a fatality has been linked to rosuvastatin. Emma Baines... - Jan 21, 2005 A CSM review of the safety of rosuvastatin concluded that its prescribing ... A patient on rosuvastatin has died from a muscle-wasting disorder which is a ... Free with registration - GP - AccessMyLibrary.com Regression of Atherosclerosis With Rosuvastatin Confirmed by QCA - Apr 8, 2008 April 8, 2008 (Chicago) — New findings presented last week at the American College of Cardiology 57th Annual Scientific Session, published simultaneously ... Medscape New Crestor(R) (rosuvastatin calcium) Indication Approved in US to... - Nov 15, 2007 WILMINGTON, DE -- November 15, 2007 -- The US Food and Drug Administration (FDA) has approved Crestor(R) (rosuvastatin calcium) as an adjunct to diet to ... DG News Statin Therapy With or Without Ezetimibe in High-Risk Patients - Jul 28, 2006 However, the doses of the statins used -- rosuvastatin 40 mg and simvastatin 80 ... The EXamination of Potential Lipid-modifying effects Of Rosuvastatin in ... Medscape A case for lower dose of rosuvastatin - Mar 17, 2005 Although the pre-approval clinical trial programme for rosuvastatin involved more than 10000 patients, by 2004 more than 42000 patients were treated with ... expresspharmapulse.com ABT-335 improved lipid levels in patients with mixed dyslipidemia and... - Jun 8, 2008 Use of the investigational drug ABT-335 in combination with rosuvastatin calcium ... The 40 mg rosuvastatin arm was included to assess safety and adverse ... Endocrine Today Rosuvastatin Shown To Be Safe And Well-tolerated Treatment For … - May 12, 2007 A multinational clinical trial program, published in the journal "Cardiology" shows that rosuvastatin is well tolerated by a broad range of patients with ... Medical News Today - Medical News Today (press release) Can intensive statin therapy cause regression of coronary atherosclero... - May 2, 2006 A Study to Evaluate the Effect of Rosuvastatin on Intravascular Ultrasound-Derived Coronary ... All enrolled patients received 40 mg rosuvastatin daily. ... Nature.com Health Canada issues advisory over statins - Jul 14, 2005 Pravachol (pravastatin) and Crestor (rosuvastatin), put some patients with pre-existing medical conditions at greater risk of muscle-related problems. ... CTV.ca Rosuvastatin does not cause regression of atherosclerosis in low-risk... - Apr 1, 2007 Use of high-dose rosuvastatin is associated with a reduction in the progression of atherosclerosis, but the agent does not cause regression of ... Free with registration - Formulary - AccessMyLibrary.com Hearty news - Apr 27, 2008 ROSUVASTATIN, a statin, has received approval in Malaysia as an ... The approval of this additional indication for rosuvastatin in Malaysia follows the US ... Malaysia Star Crestor (Rosuvastatin) May Be Associated With Arrested Progression of... - May 6, 2005 Atherosclerosis is a progressive disease and the main cause of cardiovascular disease - the number one killer worldwide.4,5 It results in a build-up of ... DG News Can a Potent Statin Actually Regress Coronary Atherosclerosis? - Mar 13, 2006 After 2 years of treatment with rosuvastatin, mean LDL-C levels decreased by ... Rosuvastatin therapy was associated with a modest decrease in mean percent ... Journal of American Medical Association - Journal of American Medical Association... Long-term Beneficial Effect of Rosuvastatin on Renal Function - Jun 12, 2007 The effect of rosuvastatin on renal function was once controversial, with calls from a public advocacy group for the drug's withdrawal in the United States ... Medscape Trial of cholesterol-busting drug proves major success - Nov 10, 2008 Yet those receiving medium doses of rosuvastatin - brand name Crestor - suffered fewer heart problems. Their risk of a heart attack was slashed by 54 per ... Scottish Daily Record Effect of rosuvastatin on renal-disease patients: Jury still out - Nov 10, 2005 Philadelphia, PA - The long-term effects of rosuvastatin (Crestor, AstraZeneca) on patients with renal disease are not yet known. ... Medscape … LDL-C Reduction Ever Shown in Patients Is Achieved With Rosuvastati... - Jul 20, 2006 ..."Several studies have already demonstrated that rosuvastatin, ... EXPLORER now shows that a treatment regimen using rosuvastatin as a base and adding-on ... DG News Effect of Rosuvastatin in Patients With Chronic Heart Failure (the... - Sep 3, 2008 Methods: The GISSI-HF: Rosuvastatin Study, a randomized, double-blind, placebo-controlled trial, was conducted in 326 cardiology and 31 internal medicine ... Cardiosource … Artery Thickening Slowed With Rosuvastatin Therapy: Presented at... - Nov 8, 2007 By Ed Susman. ORLANDO, FL -- November 8, 2007 -- Researchers said they have been able to observe that treatment with rosuvastatin slows the progression of ... DG News Post-Marketing Analysis Examines Cholesterol-Lowering Drugs' Side … - May 23, 2005 Researchers found that rosuvastatin was associated with a higher rate of ... The absolute risk of AERS with rosuvastatin appears low, with 145 muscle or ... emaxhealth.com Rosuvastatin Helped More Patients Reach Goal in MERCURY II Study - May 15, 2006 WILMINGTON, DE -- May 15, 2006 -- Results from the MERCURY II (Measuring Effective Reductions in Cholesterol Using Rosuvastatin therapY) trial, ... DG News Rosuvastatin slows carotid atherosderosis in low-risk patients.( … - May 15, 2007 NEW ORLEANS -- Rosuvastatin slowed the progression of carotid intimamedia thickness in asymptomatic subjects at low risk of cardiovascular events but who ... Free with registration - Family Practice News - AccessMyLibrary.com Clinical news updates from the 2008 American Heart Association … - Dec 1, 2008 Rosuvastatin reduces events in patients without hyperlipidemia but with elevated hdCRP Rosuvastatin treatment of patients with better-than-average lipid ... $9.94 - Formulary - Alacra Store Rosuvastatin Appears Safe and Effective for Treating Hyperlipidemia... - Nov 11, 2005 By Maria Bishop. PHILADELPHIA, PA -- November 11, 2005 -- Rosuvastatin appears to have a favorable effect on the atherogenic lipid profiles and ... DG News Sunny statin update - Dec 2, 2007 New data sheds further light on the effect of the statin rosuvastatin on heart ... NEW data from the CORONA (COntrolled ROsuvastatin MultiNAtional Trial in ... Malaysia Star Rosuvastatin reverses artery - Mar 30, 2006 By Owen Dyer. Rosuvastatin therapy doesn't just stop arterial plaque formation, it actually sends atherosclerosis into full retreat, according to a ... National Review of Medicine Rosuvastatin Increases Endothelial Progenitor Cells in Patients With ... - Jun 18, 2008 By Chris Berrie. MILAN, Italy -- June 18, 2008 -- Short-term rosuvastatin treatment significantly increases levels of endothelial progenitor cells (EPCs) in ... DG News Rosuvastatin linked to excess adverse events: use is associated with ... - Jul 1, 2005 Rosuvastatin use was associated with about 28 adverse events reports of ... "On the basis of this study, I don't know that rosuvastatin is more dangerous" ... Pay-Per-View - Family Practice News - Factiva, from Dow Jones Rosuvastatin Activates Circulating Stem and Progenitor Cells,... - Nov 5, 2007 High-dose rosuvastatin compared to placebo was found to activate circulating stem and progenitor cells, promote endogenous tissue regeneration, ... Cardiosource New Indication for Rosuvastatin - Dec 25, 2007 The US FDA has granted an additional indication for rosuvastatin (Crestor, AstraZeneca), as an adjunct to diet to slow the progression of atherosclerosis in ... Diabetes In Control … /simvastatin) significantly more effective than Crestor (rosuvastati... - Jun 19, 2006 2855 patients with high cholesterol showed that Vytorin (ezetimibe/simvastatin) was significantly more effective than Crestor (rosuvastatin) in reducing ... Pay-Per-View - Company Reports - Factiva, from Dow Jones … High-Density Lipoprotein Metabolism with Rosuvastatin in the... - Nov 9, 2007 Rosuvastatin has been shown to increase HDL cholesterol concentration, but the mechanisms ... Conclusions Rosuvastatin dose-dependently increased plasma HDL ... Journal of Clinical Endocrinology and... Rosuvastatin, CRP, and the kidney - Nov 3, 2005 Savannah, GA - An open-label, randomized trial has shown that 10 mg of rosuvastatin (Crestor, AstraZeneca) significantly reduced high-sensitivity C-reactive ... Medscape Ezetimibe/Simvastatin, Atorvastatin, or Rosuvastatin All Lower C... - Oct 15, 2007 By Crina Frincu-Mallos, PhD. NEW YORK, NY -- October 15, 2007 -- Therapy using ezetimibe/simvastatin, atorvastatin, or rosuvastatin results are equally ... DG News ACC: Confirmation that Rosuvastatin (Crestor) Regresses Coronary … - Apr 1, 2008 By Peggy Peck, Executive Editor, MedPage Today. CHICAGO, April 1 -- Reversal of coronary stenosis seen by intravascular ultrasound after two years of ... MedPage Today SOLAR: initial rosuvastatin superior to atorvastatin, simvastatin for... - Aug 1, 2007 A greater percentage of patients at high risk for cardiovascular disease are likely to reach target low-density lipoprotein cholesterol (LDL-C) levels with ... $4.95 - Formulary - ECNext Statins for aortic stenosis? Still waiting for answers - Feb 27, 2007 ...(2007) Rosuvastatin affecting aortic valve endothelium to slow the ... To examine whether rosuvastatin slows disease progression in patients with moderate ... Nature.com Say no to narrowed arteries - May 27, 2007 Participants received either a 40mg dose of rosuvastatin or a placebo. ... There was no control group, ie, all patients received 40mg rosuvastatin. ... Malaysia Star Statin Therapy Slows Progression of Arterial Thickening: Low-Risk CVD - Jun 12, 2007 ..."METEOR provides evidence that the effect of rosuvastatin on ... Rosuvastatin treatment was associated with significant reductions of 49% in LDL cholesterol ... Medscape JournalWatch: Rosuvastatin success.(Brief article) - Apr 5, 2007 Rosuvastatin slows the progression of atherosclerosis in low-risk patients, a US trial reveals. The METEOR study randomised 984 middle-aged people with a ... Free with registration - Pulse - AccessMyLibrary.com Statin drug combo achieves biggest reduction ever in bad cholesterol ... - Jun 19, 2006 The combination treatment regimen of rosuvastatin and ezetimibe achieved a 70 percent reduction in LDL-c, and in just six weeks, helped 94 percent of ... Pay-Per-View - Hindustan Times - Factiva, from Dow Jones INEGY better than Crestorâ„¢ in Achieving Multiple "Goals" for LDL- … - Jun 13, 2007 INEGY and rosuvastatin were well tolerated at all doses in the study.1 ... Rosuvastatin on Lowering of LDL-Cholesterol as well as Apo-lipoprotein B, ... Medical News Today - Medical News Today (press release) Drug combo trumps rosuvastatin in cutting LDL.(low density lipoprotein... - Nov 1, 2006 COPENHAGEN -- A combination of ezetimibe and simvastatin provides additional lipid-modifying benefits, compared with rosuvastatin monotherapy in patients ... Free with registration - Family Practice News - AccessMyLibrary.com … Court Opinions - IN RE ROSUVASTATIN CALCIUM PATENT LITIGATION … - Nov 24, 2008 11-24-2008) In Re: Rosuvastatin Calcium Patent Litigation AstraZeneca ... 021366 for rosuvastatin calcium tablets in 5, 10, 20, and 40 mg dosage forms. ... Pay-Per-View - Loislaw Federal District Court Opinions - Loislaw Strong combo data for AstraZeneca's Crestor.(product development)(Brie... - Jun 26, 2006 ...which reduced mean LDL to 2.11mmol/L. Principal investigator Christie Ballantyne said: "EXPLORER shows that a treatment regimen using rosuvastatin as a ... Free with registration - Pharma Marketletter - AccessMyLibrary.com InBrief: High-dose statin benefits.(rosuvastatin dosage for coronary ... - Mar 16, 2006 Very high doses of rosuvastatin can not only prevent arteries from deteriorating but may reverse the process, new research suggests. ... Free with registration - Pulse - AccessMyLibrary.com Rosuvastatin Treatment Prevents Progressive Kidney Inflammation and … - Sep 1, 2008 Salt-loaded, spontaneously hypertensive stroke-prone rats show progressive increases in blood pressure and proteinuria and accumulate acute-phase proteins ... Am J Pathology (subscription) Statins; Rosuvastatin helps more patients achieve LDL-C goals than … - Apr 4, 2005 According to scientists in Japan, "The prevalence of coronary heart disease (CHD) has been increasing in the past few decades in Japan, ... Pay-Per-View - Obesity & Diabetes Week - Factiva, from Dow Jones Letter: No reports of fatal rhabdomyolysis in UK linked to rosuvastati... - Jan 29, 2005 The article entitled `New warning to GPs over rosuvastatin in Asian ... There is no evidence that rosuvastatin has caused any fatalities in the UK. ... Pay-Per-View - Pulse - Factiva, from Dow Jones New Study on Effects of CRESTOR on Carotid Atherosclerosis Presented ... - Apr 24, 2005 CRESTOR (rosuvastatin calcium) is a once-daily prescription medication for use ... Combination therapy with rosuvastatin and gemfibrozil should generally be ... RedOrbit Statins, CRP test get boost from high-profile study - Dec 1, 2008 AstraZeneca Pharmaceuticals, the manufacturer of rosuvastatin, ... Rosuvastatin currently has FDA approval as an add-on to dietary efforts to lower ... American Medical News AstraZeneca's (Wilmington, DE) Crestor (rosuvastatin calcium) reduced... - Apr 1, 2005 AstraZeneca's (Wilmington, DE) Crestor (rosuvastatin calcium) reduced C-reactive protein levels by 5% more than atorvastatin in African-Americans, ... Free with registration - Applied Clinical Trials - AccessMyLibrary.com … approved revised labeling for rosuvastatin (Crestor, AstraZeneca)... - Apr 1, 2005 FDA approved revised labeling for rosuvastatin (Crestor, AstraZeneca) based on 15 months of post-marketing surveillance. The revised labeling includes ... Free with registration - Formulary - AccessMyLibrary.com InBrief: Rosuvastatin all-clear.(Commission on Human Medicines)(Brief... - Jun 28, 2007 The Commission on Human Medicines has decided to remove the black triangle from rosuvastatin after a detailed analysis of the drug's risk- benefit profile. ... Free with registration - Pulse - AccessMyLibrary.com Cholesterol Targets Now Demand Multi-drug Strategies - World Congress... - Sep 9, 2006 72% of 475 patients on rosuvastatin 10mg achieved goal, while 84% of the 476 ... However, the differences with rosuvastatin 20mg and 40mg doses compared ... Medical News Today - Medical News Today (press release) what is the difference between rosuvastatin,simstatin and atorvastin. - Oct 13, 2008 These are the different cholesterol lowering drugs. Which is better? Aren't all statin drugs the same? Each statin has its own set of side effects and some ... HealthCentral.com JAMA -- Effect of Rosuvastatin on Progression of Carotid Intima-Media... - Mar 28, 2007 You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you ... Journal of American Medical Association - Journal of American Medical Association... Article: Rosuvastatin linked to excess adverse events: use is... - Jul 1, 2005 Rosuvastatin linked to excess adverse events: use is associated with reports of rhabdomyolysis, proteinuria, nephropathy, and renal failure. Pay-Per-View - Internal Medicine News - HighBeam Research Drug Development; Study comparing safety of 3 statins with rosuvastati... - Jun 20, 2005 Researchers analyzed 145 rosuvastatin-associated adverse events reported to the ... The review found that with either comparison, rosuvastatin (Crestor) was ... Pay-Per-View - Health & Medicine Week - Factiva, from Dow Jones Weekly rosuvastatin is better tolerated.(News) | Article from Family ... - Aug 15, 2008 Weekly rosuvastatin is better tolerated.(News) ... find Family Practice News articles. TORONTO -- A once-a-week dose of rosuvastatin was at least partially ... Pay-Per-View - Family Practice News - HighBeam Research Rosuvastatin linked to excess adverse events: use is associated with ... - Jul 1, 2005 Rosuvastatin linked to excess adverse events: use is associated with reports of rhabdomyolysis, proteinuria, nephropathy, and renal failure. Pay-Per-View - Family Practice News - HighBeam Research Drug Development; Study comparing safety of 3 statins with rosuvastati... - Jun 21, 2005 Researchers analyzed 145 rosuvastatin-associated adverse events reported to the ... The review found that with either comparison, rosuvastatin (Crestor) was ... Pay-Per-View - Life Science Weekly - Factiva, from Dow Jones Article: Rosuvastatin better than atorvastatin in blacks.(Cardiovascul... - Sep 15, 2006 Rosuvastatin better than atorvastatin in blacks.(Cardiovascular Medicine)(Brief article) ... find Family Practice News articles. ATLANTA -- Rosuvastatin was ... Pay-Per-View - Family Practice News - HighBeam Research Victory Junction Gang Camp Receives $50,000 Donation Through The … - Feb 10, 2005 The CRESTOR(R) (rosuvastatin calcium) Charity Challenge is the ... CRESTOR (rosuvastatin calcium) is a once-daily prescription medication for use as an ... Euro am Sonntag Healthy Community Initiative of Greater Orlando Receives $50,000 … - Oct 24, 2005 The CRESTOR(R) (rosuvastatin calcium) Charity Challenge is the ... CRESTOR (rosuvastatin calcium) is a once-daily prescription medication for use as an ... Free with registration - PR Newswire - AccessMyLibrary.com Statins reverse atherosclerosis - Mar 17, 2006 The study included 349 patients treated with 40mg/day of rosuvastatin over 24 months, reducing their LDL by 53 per cent from a median of 3.3mmol/l to a ... Healthcare Republic - Healthcare Republic Article: No clear benefit from rosuvastatin for heart failure... - Dec 1, 2007 No clear benefit from rosuvastatin for heart failure patients.(Cardiovascular Medicine) ... find Family Practice News articles. Treatment with rosuvastatin ... Pay-Per-View - Family Practice News - HighBeam Research Article: Rosuvastatin causes atherosclerosis regression.(Cardiovascula... - May 1, 2008 Rosuvastatin causes atherosclerosis regression.(Cardiovascular Medicine)(Drug overview) ... find Internal Medicine News articles. Pay-Per-View - Internal Medicine News - HighBeam Research Press Release: Rosuvastatin (Crestor) Study Raises Safety Issues. -... - May 23, 2005 Rosuvastatin (Crestor) Study Raises Safety Issues. from PR Newswire. Highbeam Research – FREE Trial. Pay-Per-View - PR Newswire - HighBeam Research Brand Names/Synonyms: Rosuvastatin is also known by the following brand names and/or synonymsCrestor; Rosuvastatin; Rosuvastatin [Inn]; ZD 4522 Drug Category: Rosuvastatin is categorized under the following by the FDA: Anticholesteremic Agents; HMG-CoA Reductase Inhibitors; ATC:C10AA07 Dosage Forms: TABLET Absorption: 20% Interactions: [an error occurred while processing this directive] Chemical IUPAC Name: 7-[4-(4-fluorophenyl)-6-(1-methylethyl)-2-(methyl-methylsulfonyl-amino)-pyrimidin-5-yl]-3,5-dihydroxy-hept-6-enoic acid |
|
Health Home | Conditions | Cancer | Medications | Surgery | Vaccines The Cancer News Network
COPYRIGHT 2009 CANCERNEWSNETWORK | Privacy |